Positive EMERALD Trial Results for Elacestrant Presented at Sa...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
FLORENCE, Italy and BOSTON, Dec. 8, 2021 /PRNewswire-AsiaNet/ -- - Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen recept...
Authors: LATEST ASIANET NEWS RELEASES